Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
Positron emission tomography (PET) uses radioactive tracers and enables the functional imaging of several metabolic processes, blood flow measurements, regional chemical composition, and/or chemical absorption. Depending on the targeted processes within the living organism, different tracers are use...
Main Authors: | George Crișan, Nastasia Sanda Moldovean-Cioroianu, Diana-Gabriela Timaru, Gabriel Andrieș, Călin Căinap, Vasile Chiș |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/9/5023 |
Similar Items
-
Recent Developments in PET and SPECT Radiotracers as Radiopharmaceuticals for Hypoxia Tumors
by: Anh Thu Nguyen, et al.
Published: (2023-06-01) -
Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update
by: Jonatan Dewulf, et al.
Published: (2020-07-01) -
PET Oncological Radiopharmaceuticals: Current Status and Perspectives
by: Mai Lin, et al.
Published: (2022-10-01) -
Radiopharmaceuticals: From Molecular Imaging to Targeted Radionuclide Therapy
by: P. August Schubiger, et al.
Published: (2004-10-01) -
SPECT/CT and PET/CT, related radiopharmaceuticals, and areas of application and comparison
by: Fawaz F. Alqahtani
Published: (2023-02-01)